498 related articles for article (PubMed ID: 16538969)
1. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
[TBL] [Abstract][Full Text] [Related]
2. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.
Navarro JF; Mora C; Muros M; Maca M; Garca J
Am J Kidney Dis; 2003 Aug; 42(2):264-70. PubMed ID: 12900807
[TBL] [Abstract][Full Text] [Related]
3. Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage.
Laurent S
J Hypertens Suppl; 2003 Jun; 21(3):S11-8. PubMed ID: 12929470
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM
Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
[TBL] [Abstract][Full Text] [Related]
5. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
6. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
Waeber B; de la Sierra A; Ruilope LM
Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
[TBL] [Abstract][Full Text] [Related]
7. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Ruilope LM; Segura J
J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
[TBL] [Abstract][Full Text] [Related]
8. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
[TBL] [Abstract][Full Text] [Related]
9. [Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
Scheen AJ; Krzesinski JM
Rev Med Liege; 2007 Oct; 62(10):639-43. PubMed ID: 18069576
[TBL] [Abstract][Full Text] [Related]
10. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
Ratzmann KP; Raskovic M; Schimke E
Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
[TBL] [Abstract][Full Text] [Related]
11. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
[TBL] [Abstract][Full Text] [Related]
12. Determination of urinary enzymes as a marker of early renal damage in diabetic patients.
Mohammadi-Karakani A; Asgharzadeh-Haghighi S; Ghazi-Khansari M; Hosseini R
J Clin Lab Anal; 2007; 21(6):413-7. PubMed ID: 18022929
[TBL] [Abstract][Full Text] [Related]
13. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
Kopf D; Schmitz H; Beyer J; Frank M; Bockisch A; Lehnert H
Diabetes Nutr Metab; 2001 Oct; 14(5):245-52. PubMed ID: 11806464
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
Banu N; Hara H; Okamura M; Egusa G; Yamakido M
Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
[TBL] [Abstract][Full Text] [Related]
15. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
16. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients.
Uslu S; Efe B; Alataş O; Kebapçi N; Colak O; Demirüstü C; Yörük A
J Nephrol; 2005; 18(5):559-67. PubMed ID: 16299682
[TBL] [Abstract][Full Text] [Related]
17. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Waeber B
J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
Minakami H
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
[TBL] [Abstract][Full Text] [Related]
19. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
Laurent S
J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
[TBL] [Abstract][Full Text] [Related]
20. [Microalbumin and N-acetyl-beta-D-glucosaminidase in random spot urine samples as predictors of diabetic nephropathy in the elderly non-insulin dependent diabetic patients].
Hirai M; Nakano H; Oba K; Metori S
Nihon Ika Daigaku Zasshi; 1997 Dec; 64(6):518-25. PubMed ID: 9436372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
